Grace Indradjaja - PT Lippo Senior Executive Officer - Siloam Hospitals
PTLKF Stock | USD 0 0.00 0.00% |
Executive
Dr. Grace Frelita Indradjaja serves as Senior Executive Officer Siloam Hospitals of PT Lippo Karawaci Tbk. She holds Bachelor of Medicine from Universitas Katolik Indonesia Atma Jaya and Master of Management in Hospital Administration from Universitas Indonesia Esa Unggul. She was with RS Jiwa Saraf Dharma Jaya, Balai Kesehatan Masyarakat Keluarga Mulia Jakarta and RS Ongkomulyo Jakarta as a Doctor. Currently, she also serves as Director of PT Siloam International Hospiotals Tbk since 2007.
Age | 59 |
Phone | 62 21 2566 9000 |
Web | https://www.lippokarawaci.co.id |
PT Lippo Management Efficiency
PT Lippo's management efficiency ratios could be used to measure how well PT Lippo manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
Showing other executives | EXECUTIVE Age | ||
Becky Carr | CoStar Group | 51 | |
Vikramaditya Kohli | CBRE Group Class | 44 | |
Elizabeth Atlee | CBRE Group Class | N/A | |
Jonathan Coleman | CoStar Group | 53 | |
Siting Li | Ke HoldingsInc | N/A | |
Yee Lau | Ke HoldingsInc | 50 | |
Rebecca Carr | CoStar Group | 52 | |
Marc Swartz | CoStar Group | N/A | |
Scott Wheeler | CoStar Group | 60 | |
Croft Young | CBRE Group Class | N/A | |
Dara Bazzano | CBRE Group Class | 49 | |
Heather Planishek | Palantir TechnologiesInc | 40 | |
Frank Simuro | CoStar Group | 57 | |
Kevin Kawasaki | Palantir TechnologiesInc | N/A | |
Cyndi Eakin | CoStar Group | N/A | |
Chad Doellinger | CBRE Group Class | N/A | |
Gene Boxer | CoStar Group | 49 | |
Matthew Blocher | CoStar Group | N/A |
Management Performance
Return On Equity | -0.13 | |||
Return On Asset | 0.0078 |
PT Lippo Karawaci Leadership Team
Elected by the shareholders, the PT Lippo's board of directors comprises two types of representatives: PT Lippo inside directors who are chosen from within the company, and outside directors, selected externally and held independent of PTLKF. The board's role is to monitor PT Lippo's management team and ensure that shareholders' interests are well served. PT Lippo's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, PT Lippo's outside directors are responsible for providing unbiased perspectives on the board's policies.
Bartholomeus Toto, Senior Executive Officer - Lippo Homes | ||
Tanri Abeng, Independent Commissioner | ||
Heok Lee, Director | ||
Marshal Tissadharma, Director | ||
Julie McCaughan, Senior Executive Officer - Siloam Hospitals | ||
Ninik Nathan, Director | ||
Johanes Jany, Director | ||
Soerjadi Soedirdja, Vice President Commissioner, Independent Commissioner | ||
Farid Harianto, Independent Commissioner | ||
Jenny Kuistono, Corporate Secretary and Director | ||
Muladi, Independent Commissioner | ||
Ketut Wijaya, Pres Director | ||
Anthony Ross, Senior Executive Officer - Hotels & Hospitality | ||
Viven Sitiabudi, Commissioner | ||
Alwi Sjaaf, Independent Director | ||
Gordon Benton, Senior Executive Officer | ||
Budi Legowo, Senior Executive Officer - Siloam Hospitals | ||
Sri Handoyo, Corporate Secretary | ||
William Utama, IR Contact Officer | ||
Chong Meow, Senior Executive Officer | ||
H Sutiyoso, Commissioner | ||
Eddy Mumin, Senior Executive Officer - Lippo Malls | ||
Caroline Riady, Senior Executive Officer - Siloam Hospitals | ||
Theo Sambuaga, President Commissioner, Independent Commissioner | ||
Marshall Tissadharma, Senior Executive Officer - Lippo Malls | ||
Romeo Lledo, Senior Executive Officer - Siloam Hospitals | ||
Norita Alex, Director - Talent Administration | ||
Surjadi Soedirdja, Vice President Commissioner, Independent Commissioner | ||
Kooi Choo, Director | ||
Grace Indradjaja, Senior Executive Officer - Siloam Hospitals | ||
Dion Leswara, Chief Director | ||
Chee Chan, Director | ||
Edward Ng, Senior Executive Officer - Lippo Malls | ||
Rudy Halim, COO Director | ||
Krishnadi Kartawidjaja, Chief Devel | ||
Tjokro Libianto, Director | ||
Rahmawaty, Director | ||
Andi Anzhar, Senior Executive Officer - Lippo Homes | ||
Bret Ginesky, Head Relations | ||
Donny Susanto, Chief Controller | ||
John Riady, CEO Director | ||
Surya CFA, Chief Director | ||
Benny Djie, Commissioner | ||
Budiraharjo Legowo, Senior Executive Officer - Siloam Hospitals | ||
Agum Gumelar, Independent Commissioner | ||
Juergen Fischer, Senior Executive Officer - Hotels & Hospitality | ||
Kah Hong, Controller | ||
Anwar Salim, Senior Executive Officer - Lippo Malls | ||
Danang Jati, Head Communications | ||
Sunil Ithikatt, Senior Executive Officer - Hotel | ||
Anang Prayudi, Senior Executive Officer - Siloam Hospitals | ||
Sugianganto Budisuharto, Senior Executive Officer - Siloam Hospitals | ||
Gershu Chandy, Senior Executive Officer | ||
Siek Yohandra, Senior Executive Officer - Lippo Homes | ||
Jopy Rusli, Chief Officer | ||
Hendra Sidin, Vice President Director | ||
Richard Setiadi, Director | ||
Wijaya Subekti, Director | ||
Mark Wong, Investor Relations Director | ||
Meng Phua, CFO Director | ||
Andry, Senior Executive Officer - Siloam Hospitals | ||
Ivan Budiono, Director | ||
Susan Tedjadinata, Senior Executive Officer - Lippo Homes | ||
Marshall Martinus, Senior Executive Officer - Lippo Malls | ||
Purnomo Utoyo, Senior Executive Officer - Lippo Homes |
PTLKF Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is PT Lippo a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | -0.13 | |||
Return On Asset | 0.0078 | |||
Profit Margin | (0.20) % | |||
Current Valuation | 1.54 B | |||
Shares Outstanding | 70.8 B | |||
Shares Owned By Insiders | 55.70 % | |||
Shares Owned By Institutions | 4.00 % | |||
Price To Earning | 19.00 X | |||
Price To Book | 0.54 X | |||
Price To Sales | 0.62 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards PT Lippo in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, PT Lippo's short interest history, or implied volatility extrapolated from PT Lippo options trading.
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as PT Lippo Karawaci using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PT Lippo Karawaci. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in industry. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Complementary Tools for PTLKF Pink Sheet analysis
When running PT Lippo's price analysis, check to measure PT Lippo's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PT Lippo is operating at the current time. Most of PT Lippo's value examination focuses on studying past and present price action to predict the probability of PT Lippo's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PT Lippo's price. Additionally, you may evaluate how the addition of PT Lippo to your portfolios can decrease your overall portfolio volatility.
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |